News & Updates

Apixaban (Eliquis): Superior anticoagulation efficacy with minimized bleeding risks

Primary stroke mechanism identification helps predict recurrent stroke risk

In medically treated symptomatic intracranial atherosclerotic stenosis (sICAS) patients, considering artery-to-artery embolism (AAE) rather than hypoperfusion as the stroke mechanism for cortical borderzone (CBZ) infarcts could better predict early recurrent stroke in the same territory (SIT), a study by the Chinese University of Hong Kong (CUHK) has found.

Palliative care needed in patients with progressive neurologic diseases

Early recognition and management of emerging palliative care (PC) needs, particularly psychospiritual distress, is crucial for enhancing health-related quality of life (HRQoL) for patients with peripheral neurologic diseases (PNDs), a study by the University of Hong Kong (HKU) has found.  

Meta-analysis favours glucose-lowering with GLP-1RA for dementia risk

In the management of diabetes, users of glucagon-like peptide-1 receptor agonists (GLP-1RAs) appear to have a lower risk of all-cause dementia compared with users of other glucose-lowering medications, according to a systematic review and meta-analysis.

Cognitive function in middle-aged women not worsened by COVID-19 pandemic

COVID-19 pandemic and pandemic-related events do not appear to have resulted in cognitive decline in middle-aged women, according to a study.

Self-perceived stress tied to higher stroke risk in young women

A recent study found that self-perceived stress may increase the risk of early-onset cryptogenic ischaemic stroke (CIS) in young adults, particularly women.

Long-term D2 blockade not to blame for relapse in schizophrenia

Continuous dopamine D2 receptor blockade does not appear to increase the risk of breakthrough psychosis in patients with first-episode schizophrenia, as shown in a study.

Inebilizumab shows benefit in patients with gMG

Treatment with inebilizumab significantly improved generalized myasthenia gravis (gMG) symptoms, as shown by a greater reduction in MG-Activities of Daily Living (MG-ADL) scores, among patients who were acetylcholine receptor antibody-positive (AChR-Ab+) or muscle-specific kinase antibody-positive (MuSK-Ab+), according to the phase III MINT* trial presented at AAN 2025.

AI-driven, wrist-worn stimulation device reduces essential tremors

A wrist-worn wearable that harnesses artificial intelligence (AI) for noninvasive modulation of the nervous system appears beneficial in patients with essential tremor, enabling them to regain greater control over their upper limb movements for everyday activities.